Poor reproducibility of template bleeding time in horses.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
The research study evaluates the ineffectiveness of the Template Bleeding Time (TBT) test, a method to assess platelet function disorders in horses, due to its poor reproducibility and inability to detect effects of certain drugs on platelet function.
Research Objective
In the study, the researchers purposed to test the reproducibility and sensitivity of TBT on horses. They especially wanted to assess if TBT effectively ascertains the impact of a drug called etamsylate on platelet functionality.
Methodology
- The study was performed on twenty healthy horses.
- Researchers carried out the TBT test and repeated it twice, once after 2 hours and again 30 days later. They also executed the TBT test 2 hours after administering etamsylate intravenously to the horses.
Results
- When looking at TBT values obtained at different times, the team saw no significant differences. However, the variation rates for the TBT repeats were quite wide, ranging from 26.8% to 45.5%, indicating poor reproducibility.
- The determined reference range for TBT in horses was between 138.4 to 860.4 seconds, which is a wide range that undermines the test’s precision and value in a clinical setting.
- The researchers did not observe any statistically significant shortening in the average TBT value post-etamsylate administration. This indicates that TBT may not effectively measure the effect of specific drugs on platelet function.
Conclusions
The study findings indicate that TBT has a low reproducibility rate in horses and a wide reference range, making it less useful in detecting platelet function disorders in a clinical setting. The study suggests that alternatives with higher reproducibility should be considered to assess platelet function disorders in horses.
Cite This Article
Publication
Researcher Affiliations
- Servei de Medicina Interna Equina, Departament de Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Barcelona, Spain.
MeSH Terms
- Analysis of Variance
- Animals
- Bleeding Time / standards
- Bleeding Time / veterinary
- Blood Specimen Collection / methods
- Blood Specimen Collection / veterinary
- Ethamsylate / pharmacology
- Ethamsylate / therapeutic use
- Hemorrhage / drug therapy
- Hemostatics / pharmacology
- Hemostatics / therapeutic use
- Male
- Platelet Count / veterinary
- Reproducibility of Results
- Sensitivity and Specificity
Citations
This article has been cited 4 times.- Dahlgren AR, Tablin F, Finno CJ. Genetics of equine bleeding disorders. Equine Vet J 2021 Jan;53(1):30-37.
- Norris JW, Pombo M, Shirley E, Blevins G, Tablin F. Association of Factor V Secretion with Protein Kinase B Signaling in Platelets from Horses with Atypical Equine Thrombasthenia. J Vet Intern Med 2015 Sep-Oct;29(5):1387-94.
- Weigand A, Boos AM, Ringwald J, Mieth M, Kneser U, Arkudas A, Bleiziffer O, Klumpp D, Horch RE, Beier JP. New aspects on efficient anticoagulation and antiplatelet strategies in sheep. BMC Vet Res 2013 Oct 3;9:192.
- Mersich I, Bishop RC, Diaz Yucupicio S, Nobrega AD, Austin SM, Barger AM, Fick ME, Wilkins PA. Decreased Circulating Red Cell Mass Induced by Intravenous Acepromazine Administration Alters Viscoelastic and Traditional Plasma Coagulation Testing Results in Healthy Horses. Animals (Basel) 2024 Oct 28;14(21).